News >

Research Flourishes in Hematologic Malignancies at City of Hope

Kristi Rosa
Published: Thursday, Sep 05, 2019

At the 2019 OncLive® State of the Science Summit™ on Hematologic Malignancies, we asked experts from City of Hope to share insight on some of the pivotal research being conducted at their institution.

 
Steven T. Rosen, MD

Steven T. Rosen, MD

Steven T. Rosen, MD

Irell & Manella Cancer Center Director’s Distinguished Chair, Morgan & Helen Chu Director’s Chair of the Beckman Research Institute, Provost and Scientific Officer, Director, Comprehensive Cancer Center, Director, Beckman Research Institute, Director, Irell & Manella Graduate School of Biological Sciences, Professor, Department of Hematology & Hematopoietic Cell Transplantation, and Hematologist/Oncologist, City of Hope

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
2nd Annual Live Medical Crossfire®: Hematologic Malignancies OnlineSep 28, 20198.0
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Publication Bottom Border
Border Publication
x